Publications found:
36,694
Sort by:
Pharmaceutical Industry in India – Porter’s Five Forces Strategy Analysis
US$ 175.00
... markets like US and Europe. In the recent past, several pharmaceutical companies have demonstrated that they possess the ability to engage ... players in the international market. Aruvian's R'search analyzes The Pharmaceutical Industry in India in Michael Porter’s Five Forces Analysis. It uses concepts developed ...
March 2012
20 pages
Drug Industry in the United States - Porter’s Five Forces Strategy Analysis
US$ 175.00
... falling, leading to layoffs and cuts in research budgets. While the US drug industry is hardly in a full-blown crisis, however, layoffs are occurring ... taken once a week instead of daily. Aruvian's R'search analyzes the United States Drug Industry in the Michael Porter’s Five Forces Analysis. It uses concepts ...
February 2012
12 pages
Analyzing the Global Pharmaceutical Industry
US$ 450.00
... corporate enterprises. Aruvian's R'search’s report – Analyzing the Global Pharmaceutical Industry - presents a complete analysis of the global pharmaceutical industry by setting up a industry demarcation and ...
February 2012
480 pages
Pharmaceutical Industry in China
US$ 325.00
... the government in the industry, and investment opportunities in China’s Pharmaceutical Industry. Complete with a comprehensive section on the clinical ... players in the Chinese Pharmaceutical Industry, Aruvian’s latest research is a collection of all you need to know about China’s Pharmaceutical Industry.
February 2012
80 pages
Pharmaceutical Industry in China – PEST Framework Analysis
US$ 175.00
... manufacturing technology and management structure. The Chinese pharmaceutical industry also has a lower market concentration and ... competitiveness, coupled with a lack of patented pharmaceuticals developed in-house. Aruvian's R'search analyzes Pharmaceutical Industry in China in a PEST Framework Analysis. A PEST ...
February 2012
25 pages
Pharmaceutical Industry in Mexico
US$ 325.00
... cellular and molecular levels to dramatically advance the treatment of disease. Mexico’s pharmaceutical policy environment is in a period of rapid evolution, with simultaneous policy development ...
February 2012
120 pages
Pharmaceutical Industry in Poland
US$ 300.00
... on healthcare as economies boomed globally. The global presence of the pharmaceutical industry is evident with the roll out of continent specific R&D ... of hospitalization. Aruvian’s R’search brings you a complete analysis of the Pharmaceutical Industry in Denmark. The report covers a brief profile of the global ...
February 2012
100 pages
Pharmaceutical Industry in Denmark
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Denmark. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Denmark – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Sweden
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Sweden. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Sweden – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Japan
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Japan. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Japan – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Spain
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Spain. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Spain – complete with a SWOT analysis of the leading companies in ...
February 2012
145 pages
Pharmaceutical Industry in South Korea
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in South Korea. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... competition in the industry, and the key players in the pharmaceutical industry in South Korea – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in the Netherlands
US$ 300.00
... . Aruvian’s R’search brings you a complete analysis of the Pharmaceutical Industry in The Netherlands. The report covers a brief profile of the global ... competition in the industry, and the key players in the pharmaceutical industry in the Netherlands – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in Brazil
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Brazil. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Brazil – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Norway
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Norway. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Norway – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Taiwan
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Taiwan. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Taiwan – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Hungary
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Hungary. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Hungary – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Belgium
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Belgium. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Belgium – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Germany
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Germany. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Germany – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Russia
US$ 300.00
... a complete analysis of the Pharmaceutical Industry in Russia. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Russia – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Pharmaceutical Industry in Czech Republic
US$ 300.00
... complete analysis of the Pharmaceutical Industry in Czech Republic. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... in the industry, and the key players in the pharmaceutical industry in Czech Republic – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in South Africa
US$ 300.00
... complete analysis of the Pharmaceutical Industry in South Africa. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement ... in the industry, and the key players in the pharmaceutical industry in South Africa – complete with a SWOT analysis of the leading companies ...
February 2012
100 pages
Pharmaceutical Industry in Italy
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Italy. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Italy – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Meeting KOL Needs: What Pharma Needs to Know
US$ 1,445.00
The role of the Key Opinion Leader (KOL) has changed over the past 30 years. And it's about to change again.Once viewed with suspicion by their non-consulting peers, clinicians are now considered less...
February 2012
108 pages
China Chemical Pharmaceutical Industry Report, 2011
US$ 2,300.00
In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...
January 2012
112 pages
Academic Detailing: Pharma Fights Back
US$ 745.00
Ever since it was introduced three decades ago, academic detailing—which now increasingly uses pharma’s sales techniques to educate physicians—has posed a difficult issue for the industry. Governed by...
January 2012
35 pages
China Pharmaceutical Chain Industry Report, 2011
US$ 1,800.00
In China, the pharmaceutical circulation enterprises see relatively low profit margin due to many circulation links. By sales value, some 20% drugs are sold to consumers through pharmaceutical retail...
January 2012
76 pages
Pharmaceuticals: Market Research Report
US$ 1,995.00
... also recapitulates recent noteworthy mergers, acquisitions, and other strategic developments. The report briefly discusses the pharmaceutical market outlook across various markets worldwide. Regional markets extensively discussed in the report include the United States, Canada, Japan, China, Germany, South ...
January 2012
443 pages
Global Pharmaceutical & Biotechnology Outlook 2012
US$ 12,000.00
... strategic and long term investment decision making of senior management. Outlook-11’ has been tailored to deliver more meaningfully in the ... for the future, and their key milestones. The Global Pharmaceutical Model is changing. Major pharmaceutical companies continue to under-perform in a market constrained ...
December 2011
466 pages
Outlook 2012 - Japanese Pharma - Cautious Ideas to Seize Value in Happening 2012!
US$ 2,000.00
‘Japanese Pharma Top & Bottom Picks’. Our analysis suggests that 2012 is going to be a happening year for Japan Pharma on multiple fronts – while next layer of reform ... largely supporting generic companies, select innovators from Japan hold value in term of their R&D. 2012 will unfold much of this value and ...
December 2011
78 pages
Onyx Pharma, Market Perform - M&A Rumors Fuel Investors Interest and Stock Movement
US$ 90.00
Recent news about “possible acquisition of Onyx pharma” is not a surprise in light of the upcoming ... over Regorafenib (BAY73-4506, PhIII) with Bayer. Onyx product pipeline focuses only in oncology. We have ... released on 30th November, 2011 on Onyx pharma titled “M&A Rumors Fuel Investors Interest and Stock ...
November 2011
6 pages
Generic Drug Market in Canada
US$ 1,000.00
Canada is one of the world’s largest pharmaceutical markets, even though it has a low share of only 3% in global pharma industry. In 2010, generics accounted for more than 57% prescriptions and around...
November 2011
65 pages
US Pharmacy Benefit Management (PBM) Industry Report: 2011 Edition
US$ 800.00
... chronic condition has also risen. The report analyzes the US Pharmacy Benefit Management Industry. Rising drug prices, increasing drug utilization and prevalence ... , contracts for renewals of the major players and market share of PBM companies adjusted on the basis of acquisitions and contract shifts. This ...
November 2011
40 pages
Pharma Product Launches: Strategies for Success
US$ 595.00
Failed launches. It sounds a bit harsh, yet when it comes to new product launches, that has increasingly been the pharmaceutical industry’s experience since the recession. A tighter economic climate,...
October 2011
30 pages
Vaccine Pipeline Database: 1-Year Subscription
US$ 1,333.00
Subscription to La Merie’s proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use ...
October 2011
274 pages
Competitor Analysis HIV Vaccines
US$ 413.00
... (plasmid, conventional, alternative delivery and prime – boost regimens) Adenoviral vector vaccines Poxvirus vector vaccines Protein & peptide vaccines Others Corporate HIV Vaccine R&D Pipelines About Competitor Analysis Series: The Competitor Analysis Series delivers NO-FRILLS, but concise ...
October 2011
54 pages
The 2011 Global Pharmaceutical Market Dynamics and Trends
US$ 1,480.00
A 25-page worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for key geographic regions: North America, Europe, Japan, Latin America. Sales ...
September 2011
25 pages
Asia Pacific Pharmaceutical Market: Strategic Assessments of Leading Suppliers
US$ 7,840.00
... executives with strategically significant competitor information and analysis of the leading players in the Asia Pacific pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. ...
September 2011
1353 pages
